ArticleIn vivo (Athens, Greece)

Sodium-Glucose Cotransporter 2 Inhibitors and Reduced Fibromyalgia Risk in Patients With Diabetes: A Target Trial Emulation Study.

Yi-Sheng Jhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.